Annual Accounts Payable
$6.98 M
+$5.76 M+472.69%
December 31, 2023
Summary
- As of February 8, 2025, PDSB annual accounts payable is $6.98 million, with the most recent change of +$5.76 million (+472.69%) on December 31, 2023.
- During the last 3 years, PDSB annual accounts payable has risen by +$5.57 million (+393.41%).
- PDSB annual accounts payable is now at all-time high.
Performance
PDSB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.30 M
-$1.95 M-60.00%
September 30, 2024
Summary
- As of February 8, 2025, PDSB quarterly accounts payable is $1.30 million, with the most recent change of -$1.95 million (-60.00%) on September 30, 2024.
- Over the past year, PDSB quarterly accounts payable has dropped by -$5.68 million (-81.37%).
- PDSB quarterly accounts payable is now -81.37% below its all-time high of $6.98 million, reached on December 31, 2023.
Performance
PDSB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PDSB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +472.7% | -81.4% |
| 3 y3 years | +393.4% | -70.5% |
| 5 y5 years | +1648.3% | -70.5% |
PDSB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +472.7% | -81.4% | +6.7% |
| 5 y | 5-year | at high | +483.0% | -81.4% | +36.9% |
| alltime | all time | at high | +1648.3% | -81.4% | +225.7% |
PDS Biotechnology Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.30 M(-60.0%) |
| Jun 2024 | - | $3.25 M(-45.8%) |
| Mar 2024 | - | $6.00 M(-14.1%) |
| Dec 2023 | $6.98 M(+472.7%) | $6.98 M(+30.1%) |
| Sep 2023 | - | $5.37 M(+21.6%) |
| Jun 2023 | - | $4.41 M(+113.1%) |
| Mar 2023 | - | $2.07 M(+69.9%) |
| Dec 2022 | $1.22 M(-6.9%) | $1.22 M(-40.2%) |
| Sep 2022 | - | $2.04 M(+8.5%) |
| Jun 2022 | - | $1.88 M(-31.6%) |
| Mar 2022 | - | $2.75 M(+109.7%) |
| Dec 2021 | $1.31 M(-7.5%) | $1.31 M(-9.4%) |
| Sep 2021 | - | $1.45 M(-39.1%) |
| Jun 2021 | - | $2.38 M(+149.9%) |
| Mar 2021 | - | $950.60 K(-32.8%) |
| Dec 2020 | $1.42 M(+18.2%) | $1.42 M(-9.3%) |
| Sep 2020 | - | $1.56 M(+42.8%) |
| Jun 2020 | - | $1.09 M(-57.3%) |
| Mar 2020 | - | $2.56 M(+113.5%) |
| Dec 2019 | $1.20 M | $1.20 M(-19.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $1.49 M(-19.7%) |
| Jun 2019 | - | $1.85 M(-30.5%) |
| Mar 2019 | - | $2.67 M(+567.3%) |
| Dec 2018 | $399.40 K(-90.9%) | $399.40 K(-32.4%) |
| Sep 2018 | - | $590.70 K(-65.7%) |
| Jun 2018 | - | $1.72 M(-41.7%) |
| Mar 2018 | - | $2.96 M(-32.3%) |
| Dec 2017 | $4.37 M(+25.9%) | $4.37 M(+47.4%) |
| Sep 2017 | - | $2.96 M(-31.8%) |
| Jun 2017 | - | $4.35 M(+72.1%) |
| Mar 2017 | - | $2.53 M(-27.2%) |
| Dec 2016 | $3.47 M(+34.3%) | $3.47 M(+76.8%) |
| Sep 2016 | - | $1.96 M(-31.2%) |
| Jun 2016 | - | $2.85 M(-1.0%) |
| Mar 2016 | - | $2.88 M(+11.6%) |
| Dec 2015 | $2.58 M(+26.3%) | $2.58 M(-2.3%) |
| Sep 2015 | - | $2.65 M(+143.9%) |
| Jun 2015 | - | $1.08 M(-47.0%) |
| Dec 2014 | $2.05 M(+88.2%) | $2.05 M |
| Dec 2013 | $1.09 M | - |
FAQ
- What is PDS Biotechnology annual accounts payable?
- What is the all time high annual accounts payable for PDS Biotechnology?
- What is PDS Biotechnology annual accounts payable year-on-year change?
- What is PDS Biotechnology quarterly accounts payable?
- What is the all time high quarterly accounts payable for PDS Biotechnology?
- What is PDS Biotechnology quarterly accounts payable year-on-year change?
What is PDS Biotechnology annual accounts payable?
The current annual accounts payable of PDSB is $6.98 M
What is the all time high annual accounts payable for PDS Biotechnology?
PDS Biotechnology all-time high annual accounts payable is $6.98 M
What is PDS Biotechnology annual accounts payable year-on-year change?
Over the past year, PDSB annual accounts payable has changed by +$5.76 M (+472.69%)
What is PDS Biotechnology quarterly accounts payable?
The current quarterly accounts payable of PDSB is $1.30 M
What is the all time high quarterly accounts payable for PDS Biotechnology?
PDS Biotechnology all-time high quarterly accounts payable is $6.98 M
What is PDS Biotechnology quarterly accounts payable year-on-year change?
Over the past year, PDSB quarterly accounts payable has changed by -$5.68 M (-81.37%)